查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552598

美国下肢静脉曲张治疗设备市场：2024-2030年按类型、份额、趋势分析报告、按细分市场预测的市场规模

U.S. Varicose Vein Treatment Devices Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation/ Stripping), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 75 Pages | 商品交期: 2-10个工作天内

价格

美国静脉曲张治疗设备市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，美国静脉曲张治疗器材市场规模预计将达到7.951亿美元，2024年至2030年的复合年增长率为5.5%。

由于肥胖、怀孕、久坐的生活方式和长时间站立等身体活动等危险因素导致的静脉曲张患病率较高，预计将推动市场成长。

由于年龄增长以及高血压、静脉血栓症等疾病的发病等因素，60岁以上人口静脉疾病盛行率高达26%。 0至17岁族群中发生率最低，为17%，主要原因是遗传、肥胖以及影响动脉及静脉的文明病等危险因子。

由于持续的研发活动，技术不断进步预计将推动静脉曲张治疗设备市场的发展。主要市场参与者正在进行的许多临床试验正在研究新系统相对于传统治疗方法的使用，以获得相对于现有设备的竞争优势。这提高了进入市场的产品品质并增加了市场竞争。例如，2019年6月，华盛顿湖血管中心针对接受Venaseal和静脉内热消融治疗的有症状静脉曲张患者进行了一项研究。

2015年，美国在手术和非手术整容手术上总共花费了135亿美元。自2011年以来，非手术治疗的比例增加了44%，占整容手术总支出的42%。这些统计数据强调，静脉曲张治疗设备市场对于美容目的具有吸引力。

美国静脉曲张治疗设备市场报告亮点：

  • 按类型划分，硬化疗法将在 2023 年占据最大的市场占有率。
  • 医疗保险为静脉曲张的硬化疗法提供承保，因此医疗保健提供者和患者的采用率很高。
  • 在美国静脉曲张治疗设备市场运作的主要企业包括 Medtronic plc、AngioDynamics, Inc.、Biolitec AG、Lumenis Ltd.、Syneron Medical Ltd.、Energist Group、Eufoton srl、Quanta Systems SpA、Teleflex , Inc.。
  • 2015 年 2 月，Medtronic（当时称为 Covidien）的新产品 VenaSeal 封闭系统获得美国食品药物管理局(FDA) 的上市前核准。该系统是微创的，使用医用黏剂来闭合患有静脉疾病的患者受损的静脉。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析

第四章按类型分類的业务分析

  • 类型细分仪表板
  • 美国静脉曲张治疗设备市场类型变化分析
  • 2018-2030年美国下肢静脉曲张治疗设备市场规模及趋势分析（依类型）
  • 静脉消融
    • 2018-2030 年静脉消融市场估计与预测
    • 静脉雷射治疗
    • 射频消融术
  • 硬化疗法
    • 2018-2030 年硬化疗法市场估计与预测
  • 手术结扎/剥离
    • 2018-2030年手术结扎/剥离市场估计与预测

第五章竞争状况

  • 公司分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Medtronic
    • AngioDynamics
    • Candela Corporation
    • Lumenis Be Ltd.
    • biolitec Holding GmbH &Co KG
    • Eufoton srl
    • Energist
    • Teleflex Incorporated
Product Code: GVR-4-68038-116-0

U.S. Varicose Vein Treatment Devices Market Growth & Trends:

The U.S. varicose vein treatment devices market size is expected to reach USD 795.1 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as obesity, pregnancy, sedentary lifestyle, and physical activities like standing for longer durations is expected to drive the market growth.

The prevalence of vein diseases is high in population above 60 years at 26%, owing to the factors such as increasing age and development of conditions like hypertension and venous thrombosis. The incidence is lowest in the age group of 0 to 17 at 17% and is majorly due to the risk factors such as genetics, obesity, and lifestyle-related disorders affecting the arteries and veins.

Increasing technological advancements due to continuous R&D activities are anticipated to drive the market for varicose vein treatment devices. Many ongoing clinical trials conducted by the key market players study the use of novel systems over traditional treatment methods to gain a competitive edge over the existing devices. This increases competition in the market enhancing the quality of products introduced in the market. For instance, in June 2019, the Lake Washington Vascular Centre conducted a study based on patients with symptomatic varicose veins treated with Venaseal and Endovenous Thermal Ablation.

The total expenditure of Americans on combined surgical and nonsurgical cosmetic procedures was USD 13.5 billion in 2015. The percentage of nonsurgical procedures has grown by 44% since 2011 and accounted for 42% of the total expenditure done on cosmetic procedures. These statistics highlight that the market for varicose vein treatment devices is attractive for cosmetics purposes.

U.S. Varicose Vein Treatment Devices Market Report Highlights:

  • Based on type, sclerotherapy accounted for the largest market share in 2023
  • Medicare offers insurance for sclerotherapy procedures for varicose veins, resulting in its high adoption by the healthcare providers and patients
  • Some of the key players operating in the U.S. varicose vein treatment devices market are Medtronic plc; AngioDynamics, Inc.; Biolitec AG; Lumenis Ltd.; Syneron Medical Ltd.; Energist Group; Eufoton srl; Quanta Systems S.p.A.; and Teleflex, Inc.
  • In February 2015, Medtronic (then Covidien) received a pre-market approval from the U.S. Food and Drug Administration (FDA) for their new product, VenaSeal closure system-a minimally invasive and uses a medical adhesive to close the damaged vein in patients with vein diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing preference for minimally invasive treatment procedures
      • 3.2.1.2. Introduction of technologically advanced devices
      • 3.2.1.3. Increasing geriatric population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High procedural costs and inconsistent reimbursement structure
      • 3.2.2.2. Risk factors associated with varicose veins treatment
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Varicose Vein Treatment Devices Market Type Movement Analysis
  • 4.3. U.S. Varicose Vein Treatment Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Endovenous Ablation
    • 4.4.1. Endovenous ablation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Endovenous laser therapy
      • 4.4.2.1. Endovenous laser therapy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Radiofrequency ablation
      • 4.4.3.1. Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Sclerotherapy
    • 4.5.1. Sclerotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Surgical Ligation/Stripping
    • 4.6.1. Surgical Ligation/Stripping market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

  • 5.1. Company Categorization
  • 5.2. Strategy Mapping
  • 5.3. Company Market Position Analysis, 2023
  • 5.4. Company Profiles/Listing
    • 5.4.1. Medtronic
      • 5.4.1.1. Overview
      • 5.4.1.2. Financial Performance
      • 5.4.1.3. Product Benchmarking
      • 5.4.1.4. Strategic Initiatives
    • 5.4.2. AngioDynamics
      • 5.4.2.1. Overview
      • 5.4.2.2. Product Benchmarking
      • 5.4.2.3. Strategic Initiatives
    • 5.4.3. Candela Corporation
      • 5.4.3.1. Overview
      • 5.4.3.2. Financial Performance
      • 5.4.3.3. Product Benchmarking
      • 5.4.3.4. Strategic Initiatives
    • 5.4.4. Lumenis Be Ltd.
      • 5.4.4.1. Overview
      • 5.4.4.2. Product Benchmarking
      • 5.4.4.3. Strategic Initiatives
    • 5.4.5. biolitec Holding GmbH & Co KG
      • 5.4.5.1. Overview
      • 5.4.5.2. Product Benchmarking
      • 5.4.5.3. Strategic Initiatives
    • 5.4.6. Eufoton s.r.l.
      • 5.4.6.1. Overview
      • 5.4.6.2. Financial Performance
      • 5.4.6.3. Product Benchmarking
      • 5.4.6.4. Strategic Initiatives
    • 5.4.7. Energist
      • 5.4.7.1. Overview
      • 5.4.7.2. Financial Performance
      • 5.4.7.3. Product Benchmarking
      • 5.4.7.4. Strategic Initiatives
    • 5.4.8. Teleflex Incorporated
      • 5.4.8.1. Overview
      • 5.4.8.2. Financial Performance
      • 5.4.8.3. Product Benchmarking
      • 5.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S. varicose vein treatment devices market, by type, 2018 - 2030 (USD Million)
  • Table 4 Key companies undergoing expansions.
  • Table 5 Key companies undergoing acquisitions.
  • Table 6 Key companies undergoing collaborations.
  • Table 7 Key companies launching new products/services.
  • Table 8 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. varicose vein treatment devices market: market outlook
  • Fig. 7 U.S. varicose vein treatment devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. varicose vein treatment devices market driver impact
  • Fig. 10 U.S. varicose vein treatment devices market restraint impact: Type movement analysis
  • Fig. 11 U.S. varicose vein treatment devices market: Type outlook and key takeaways
  • Fig. 12 Endovenous Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Endovenous laser therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Sclerotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Surgical Ligation/Stripping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Market share of key market players - U.S. varicose vein treatment devices market